Sarasota, Florida – Biom Pharmaceutical Corporation, a leading provider in microbiome technology, is pleased to announce the successful completion of OSHA’s 10-Hour General Industry Certification program by employees across multiple departments, including Manufacturing, Quality Control, and Supply Chain. This milestone reflects Biom’s unwavering commitment to ensuring a safe and secure work environment for all employees.
Under the leadership of Kathleen Pretty, Supply Chain Manager and Head of Biom’s Safety Leadership Team, employees demonstrated exceptional dedication and commitment to safety by completing the rigorous certification program. This achievement underscores Biom’s proactive approach to enhancing safety measures and promoting a culture of safety throughout the organization.
Kathleen Pretty commented, “The employees have shown strong commitment by completing OSHA’s 10-hour General Industry Certification program. Their accomplishment of completing this course will be important as we continue to pursue safety at Biom.”
Eric Rueping, SVP of Operations and executive sponsor of Biom’s Safety Leadership Team, expressed pride in the employees’ dedication and accomplishments, stating, “We are proud of each employee’s dedication and accomplishment under Kathleen Pretty’s steadfast leadership to advance the safety culture within Biom. Each employee who completes the 10-hour program will help drive continuous employee safety measures. Employee safety is top of mind every day at Biom. This certification obtained by our Leadership Team employees is the first step in our ongoing commitment to bettering the proactive safety program and culture as we grow.”
The completion of OSHA’s 10-Hour General Industry Certification program signifies Biom’s commitment to prioritizing safety and underscores its dedication to maintaining the highest standards of safety excellence in all operations.
For more information about Biom and its commitment to safety, please visit https://biomprobiotics.com/
About Biom Pharmaceutical Corporation
Biom Pharmaceutical is committed to the lofty goal of adding healthy years to the human lifespan by regulating the human microbiome through probiotics. This mission is at the heart of everything at Biom, from early research to product development. Biom Pharmaceutical is a pioneer in microbiome technology with five issued US Patents and has developed LiveBiom® Fermentation Technology to create humanized designer microbiome that has wide applications in human health and disease including immune regulation, cardiometabolic health, vaginal health, and neurodegeneration. Biom has developed True-To-Label nutritional supplements and has four consumer brands with twenty-three products in the market; Biom Probiotics® Total Gut Health products, VagiBiom® Feminine Care Products; Longiva® Antiaging and Longevity products, and LeanBiom®metabolic weight maintenance products.
Media ContactCompany Name: Otter PRContact Person: Gabrielle LaskEmail: Send EmailCity: OrlandoState: FloridaCountry: United StatesWebsite: OtterPR.com
